A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy

BACKGROUND: Fatigue is common among glioma patients undergoing radiotherapy (RT) and impacts quality of life (QOL). We evaluated whether armodafinil, a wakefulness-promoting medication, improves fatigue in glioma patients undergoing RT. METHODS: Eligibility criteria included age ≥18 years, Karnofsky...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Lee, Eudocia Q., Muzikansky, Alona, Drappatz, Jan, Kesari, Santosh, Wong, Eric T., Fadul, Camilo E., Reardon, David A., Norden, Andrew D., Nayak, Lakshmi, Rinne, Mikael L., Alexander, Brian M., Arvold, Nils D., Doherty, Lisa, Stefanik, Jennifer, LaFrankie, Debra, Ruland, Sandra F., Pulverenti, Julee, Smith, Katrina H., Gaffey, Sarah C., Hammond, Samantha, Wen, Patrick Y.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2016
Gaiak:
Clinical Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864265/
https://ncbi.nlm.nih.gov/pubmed/26902850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now007
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak